Ownership as of February 10, 2023. Ten largest shareholders.
Name
Series A shares
Series B shares
Share capital %
Voting rights %
ANNWALL & ROTHSCHILD INVESTMENTS AB
377 736
510 478
8.09
29.31
SIX SIS AG, W8IMY
0
1 194 861
10.64
8.17
FJÄRDE AP-FONDEN
0
1 120 000
9.98
7.66
SWEDBANK ROBUR NY TEKNIK BTI
0
540 000
4.81
3.69
AMF AKTIEFOND SMÅBOLAG
0
501 585
4.47
3.43
TREDJE AP-FONDEN
0
501 579
4.47
3.43
SKANDINAVISKA ENSKILDA BANKEN AB, W8IMY
0
347 673
3.10
2.38
ÅLANDSBANKEN ABP
0
331 390
2.95
2.27
UNIONEN
0
322 196
2.87
2.20
DANGOOR, DAVID
0
306 421
2.73
2.10
Sub-total
377 736
5 676 183
54.11
64.64
Other shareholders
0
5 172 265
45.89
35.36
Total
377 736
10 848 448
100.00
100.00
Source: Euroclear Sweden AB
The total registered share capital of Infant Bacterial Therapeutics AB consists of 377,736 class A shares with 10 votes per share and 10,848,448 class B shares with one vote per share, in total 11,226,184 shares.